Delivery Order SPE2DB20D1004-SPE2DB24FF4U2
Award Date
2/23/24
Potential Completion Date
2/26/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,965.23 firm fixed-price delivery order is for the supply of Olmesartan Medoxomil 40 mg tablets in 90-count bottles. The contract has an ultimate completion date of April 9, 2024 and was awarded on April 8, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,047.52 firm fixed-price delivery order is for the supply of Olmesartan Medoxomil 40 mg tablets. The contract has an ultimate completion date of May 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,531.10, is a delivery order for the supply of Olmesartan Medoxomil 40 mg tablets. The contract has an ultimate completion date of June 18, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with an ID of SPE2DB22D2009|SPE2DB25FL6DH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,332.14 firm fixed price delivery order is for the supply of 4,566,264,640 Olmesartan Medoxomil 40 mg tablets. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,567.90 firm fixed-price delivery order is for the supply of Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of July 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,149.84 firm-fixed-price delivery order is for the supply of Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,453.89 fixed-price delivery order is for the supply of 4,562,817,379 units of the drug Olmesartan Medoxomil 40 mg tablets, with a completion date of November 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, with an ID of SPE2DB25D3001|SPE2DB25FQTUN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,663.13 firm-fixed-price delivery order covers the supply of Olmesartan Medoxomil 40 mg tablets to support federal healthcare programs. The contract has a performance period through December 20, 2024 and does not include any set-aside designations. Amerisourcebergen...
This federal contract award, with the ID SPE2DB20D2104|SPE2DB25FMJJP, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,638.68 firm fixed-price delivery order is for the supply of 4567326451 - Olmesartan Medoxomil 40 mg tablets, with a completion date of February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,545.34 firm fixed-price delivery order is for Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...